TRIAL DATA
Adding immunotherapy to chemotherapy before surgery in stage III colon cancer — Clinical Colorectal Cancer
The AZUR-4 trial is a Phase 2, open label, randomized study of neoadjuvant dostarlimab plus CAPEOX versus CAPEOX in previously untreated T4N0 or stage III mismatch repair proficient/microsatellite stable resectable colon cancer.
If you have stage III colon cancer that is MSS or pMMR, ask your oncologist whether this trial might be appropriate for you.